ABU Qualifying Exam study materials
ABU Qualifying Exam study resources

Febrile UTI with Obstruction in a Pregnant Woman

ABU Qualifying Exam · Put your knowledge to work in context.

All case studies

Febrile UTI with Obstruction in a Pregnant Woman

A 26-year-old woman, 24 weeks pregnant (G2P1), presents with 2 days of fever to 39.2°C, right flank pain, rigors, and vomiting. She has a history of recurrent UTIs and a known 8 mm right renal calculus from 2 years ago. BP 96/58, HR 118, temperature 39.0°C, RR 22. Urinalysis: nitrite positive, leukocyte esterase 3+, WBC >100/hpf, many bacteria. Serum creatinine 1.1 (baseline 0.7), WBC 18,000, platelets 140,000. She is tachycardic and looks unwell. She is on no antibiotics.

1. What is your immediate management priority, and how does pregnancy change your approach to imaging and source control?

Read the worked answer

Priority: sepsis from obstructed infected kidney. This is a urologic emergency - pyelonephritis with a likely obstructing stone in a pregnant patient. The combination of fever, tachycardia, hypotension, and rising creatinine suggests sepsis and possible obstructive uropathy.

Immediate steps:

  1. Resuscitation: IV fluids (balanced crystalloid), blood cultures, urine culture, CBC, lactate, electrolytes, renal function.
  2. Empiric IV antibiotics - cover gram-negatives; in pregnancy, cephalosporins (e.g., ceftriaxone) are safe. Avoid fluoroquinolones and aminoglycosides if alternatives exist (aminoglycosides are a risk to fetal eighth nerve). Adjust to culture.
  3. Source control is the key step - antibiotics alone will not clear an obstructed infected system. Decompression is mandatory.

Imaging in pregnancy:

  • Renal ultrasound first - safe, no radiation; assesses hydronephrosis. However, physiologic hydronephrosis of pregnancy (especially right side) can confound interpretation.
  • If ultrasound is equivocal and obstruction is suspected, MR urography (without gadolinium) is preferred over CT. Low-dose CT is acceptable if it will change management and other modalities are unavailable - the risk of untreated sepsis outweighs radiation risk.
  • Avoid gadolinium unless essential.

Source control options:

  • Ureteral stent or percutaneous nephrostomy - both are acceptable. Stent placement under local anesthesia/light sedation; nephrostomy if stent fails or anatomy is difficult. Definitive stone treatment (ureteroscopy) can be deferred to postpartum unless the stone must be removed.
  • Do not delay decompression for imaging perfection - if she is septic with a known stone and hydronephrosis, proceed.

2. She is septic and the right kidney is hydronephrotic on ultrasound. Compare ureteral stent vs percutaneous nephrostomy in this setting, and justify your choice.

Read the worked answer

Both achieve decompression; choice depends on patient and anatomy.

Ureteral stent:

  • Pros: internal, no external tube, can be placed cystoscopically under local anesthesia, familiar to urologists.
  • Cons: requires passage past the stone (may fail if stone is large/impacted or ureter is edematous), needs anesthesia/sedation, stent symptoms (irritation, urgency) are common and may be poorly tolerated in pregnancy, encrustation risk if left long-term, and can migrate.
  • In pregnancy, stent placement is often successful but the physiologic ureteral dilation of pregnancy can both help and hinder.

Percutaneous nephrostomy (PCN):

  • Pros: reliable decompression even when the stone cannot be bypassed; can be done under local anesthesia with ultrasound guidance; allows access for future stone treatment.
  • Cons: external tube, risk of dislodgement, infection of the tube, requires radiology/interventional support, and patient must manage a drainage bag.

In this septic patient:

  • If the stone is small and the ureter can be bypassed, stent is reasonable and avoids an external tube.
  • If stent placement fails or the patient is unstable, PCN is the safer definitive decompression. Given sepsis and a known 8 mm stone (likely impacted), I would be prepared for PCN if stent fails.
  • Either way, decompress urgently - do not wait for culture results.

Key trap: Assuming antibiotics alone suffice in an obstructed infected system - they do not. Also, do not defer decompression for definitive stone surgery; temporize.

3. After decompression and 48 hours of antibiotics she improves. Outline your plan for the remainder of pregnancy and definitive stone management.

Read the worked answer

Remainder of pregnancy:

  • Complete the antibiotic course (often 7–14 days IV/oral based on culture), then suppressive antibiotics for the rest of pregnancy (e.g., cephalexin or nitrofurantoin - avoid nitrofurantoin at term due to hemolytic anemia risk in the neonate).
  • Monitor the stent/PCN: stents in pregnancy encrust faster; plan exchange every 4–6 weeks if a stent is left in situ. PCN tubes need regular changes and site care.
  • Repeat urine cultures monthly and treat asymptomatic bacteriuria (in pregnancy, treat even asymptomatic bacteriuria).
  • Serial renal ultrasound to monitor hydronephrosis and stone position.
  • Counsel on symptoms of recurrent infection or obstruction.

Definitive stone management:

  • Defer definitive treatment to postpartum if the patient remains stable - ureteroscopy can be performed in pregnancy if necessary (second trimester is safest), but elective definitive treatment is generally postponed.
  • Postpartum: Ureteroscopy with laser lithotripsy for the 8 mm stone; if it is a proximal stone, consider SWL or PCNL depending on anatomy and stone burden. An 8 mm stone is unlikely to pass spontaneously.
  • Metabolic evaluation - she has recurrent UTIs and a stone; check calcium, uric acid, citrate, oxalate, and consider a stone analysis.
  • Prevent recurrence: hydration, dietary counseling, and treat any anatomic predisposition.

Key trap: Leaving a stent in for the entire pregnancy without exchange - encrustation and infection risk. Also, forgetting suppressive antibiotics and monthly cultures.